Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

About Atopic Dermatitis Atopic Dermatitis (AD), a form of eczema, is a chronic inflammatory skin condition characterized by areas of dry skin that are red and intensely itchy. Rigorous moisturizing ...

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Atopic Dermatitis, commonly known as eczema, manifests as chronic, itchy, and inflamed skin persisting from childhood ... may increase the risk. Treatment Homeopathic treatments, derived from natural ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

Several key players are shaping the global pruritus therapeutics market. Companies such as Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

As seasons change, increased itching can occur; hydrate, moisturize, and choose soft fabrics to alleviate discomfort ...

Zenrelia is a once-daily oral tablet for canine allergic itch and inflammation. Learn more about this new treatment for dogs.